Loading...
Sitagliptin
India Pharmaceutical Trade Intelligence
Who Supplies Sitagliptin to India from SINGAPORE
India's sitagliptin imports from SINGAPORE total $12.0K across 10 shipments from 4 foreign suppliers. Bilcare GCS Inc leads with $4.5K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for sitagliptin — a diversified sourcing base with multiple active suppliers from SINGAPORE.
Top foreign suppliers (SINGAPORE) — Ranked by import value
Bilcare GCS Inc is the leading Sitagliptin supplier from SINGAPORE to India, with import value of $4.5K across 2 shipments. The top 5 suppliers — Bilcare GCS Inc, SPRING BIO SOLUTION PTE.LTD, SPRING BIO SOLUTION PTE LTD, VENUS ALPHA GENERAL TRADING LLC — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (SINGAPORE)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | Bilcare GCS Inc | $4.5K | 2 | 37.6% |
| 2 | SPRING BIO SOLUTION PTE.LTD | $3.7K | 3 | 31.3% |
| 3 | SPRING BIO SOLUTION PTE LTD | $2.0K | 3 | 17.0% |
| 4 | VENUS ALPHA GENERAL TRADING LLC | $1.7K | 2 | 14.1% |
Showing top 4 of 4 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from SINGAPORE)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $10.3K | 8 | 85.9% |
| 2 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $1.7K | 2 | 14.1% |
Import Statistics
- Import Value
- $12.0K
- Shipments
- 10
- Foreign Suppliers
- 4
- Indian Buyers
- 2
- Avg. Shipment
- $1.2K
Other Sitagliptin Import Origins
Related Analysis
Frequently Asked Questions — Sitagliptin Imports from SINGAPORE
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Sitagliptin suppliers from SINGAPORE to India?
The top Sitagliptin suppliers from SINGAPORE to India include Bilcare GCS Inc, SPRING BIO SOLUTION PTE.LTD, SPRING BIO SOLUTION PTE LTD. The leading supplier is Bilcare GCS Inc with import value of $4.5K USD across 2 shipments. India imported Sitagliptin worth $12.0K USD from SINGAPORE in total across 10 shipments.
QHow much Sitagliptin does India import from SINGAPORE?
India imported Sitagliptin worth $12.0K USD from SINGAPORE across 10 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Sitagliptin from SINGAPORE?
The main Indian buyers of Sitagliptin sourced from SINGAPORE include MYLAN LABORATORIES LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $10.3K in imports across 8 shipments.
QWhat is the total value of Sitagliptin imports from SINGAPORE to India?
The total value of Sitagliptin imports from SINGAPORE to India is $12.0K USD, across 10 shipments and 4 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: SINGAPORE to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Sitagliptin.
- 2.Supplier/Buyer Matching: 4 foreign suppliers from SINGAPORE and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $12.0K aggregated from 10 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
4 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists